Schizophrenia
|
0.500 |
GeneticVariation
|
disease |
GWASCAT |
Genome-Wide Association Study Detected Novel Susceptibility Genes for Schizophrenia and Shared Trans-Populations/Diseases Genetic Effect.
|
30285260 |
2019 |
Schizophrenia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Therefore, sustained elevation of hippocampal-prefrontal theta coherence may underlie a failure in regulating novelty-related selective attention leading to aberrant salience, and thereby represents a mechanistic link between GRIA1 and schizophrenia.
|
31000699 |
2019 |
Schizophrenia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Genome-wide association studies have suggested a link between schizophrenia and genes associated with synaptic plasticity, including the Gria1 gene which codes for the GluA1 subunit of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor.
|
30108203 |
2018 |
Schizophrenia
|
0.500 |
Biomarker
|
disease |
BEFREE |
The GluA1 AMPAR subunit (encoded by the Gria1 gene) has been implicated in schizophrenia.
|
28496171 |
2017 |
Schizophrenia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Here, we tested the ability of LY354740 to rescue spatial working memory performance in mice that lack the GluA1 subunit of the AMPA glutamate receptor, encoded by Gria1, a gene recently implicated in schizophrenia by genome-wide association studies.
|
28186680 |
2017 |
Schizophrenia
|
0.500 |
Biomarker
|
disease |
BEFREE |
While GluA1 is important for cognition, it is not clear what the role of GluA1 is in hedonic responses that are relevant to the negative symptoms of disorders such as schizophrenia.
|
28785046 |
2017 |
Schizophrenia
|
0.500 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide association study of schizophrenia in Ashkenazi Jews.
|
26198764 |
2015 |
Schizophrenia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
What causes aberrant salience in schizophrenia? A role for impaired short-term habituation and the GRIA1 (GluA1) AMPA receptor subunit.
|
25224260 |
2014 |
Schizophrenia
|
0.500 |
Biomarker
|
disease |
PSYGENET |
A significantly increased risk of schizophrenia was associated with the A allele of rs1428920 and rs2926835 of GRIA1.
|
23053966 |
2012 |
Schizophrenia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
A significantly increased risk of schizophrenia was associated with the A allele of rs1428920 and rs2926835 of GRIA1.
|
23053966 |
2012 |
Schizophrenia
|
0.500 |
GeneticVariation
|
disease |
BEFREE |
Our findings provide no evidence for an association between SNPs within GRIA1, GRIA2 and GRIA4 under investigation and schizophrenia susceptibility, although rs3813296 (GRIA2) could be associated with improvement on PANSS negative scores.
|
22094384 |
2012 |
Schizophrenia
|
0.500 |
Biomarker
|
disease |
PSYGENET |
Do GluA1 knockout mice exhibit behavioral abnormalities relevant to the negative or cognitive symptoms of schizophrenia and schizoaffective disorder?
|
21693126 |
2012 |
Schizophrenia
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
These data suggest that increased GRIA1 subunit expression may contribute to schizophrenia pathology.
|
17942280 |
2007 |
Schizophrenia
|
0.500 |
Biomarker
|
disease |
BEFREE |
The glutamatergic hypothesis of schizophrenia lead recently to a first successful mGlu2/3 receptor agonistic drug and is underpinned by significant findings in genes regulating the glutamatergic system (SLC1A6, SLC1A2 GRIN1, GRIN2A, GRIA1, NRG1, ErbB4, DTNBP1, DAAO, G72/30, GRM3).
|
17982252 |
2007 |
Schizophrenia
|
0.500 |
Biomarker
|
disease |
BEFREE |
Therefore our data indicate that GRIA1 may be involved in susceptibility to DSM-IV-TR schizophrenia.
|
16526023 |
2006 |
Schizophrenia
|
0.500 |
Biomarker
|
disease |
LHGDN |
Therefore our data indicate that GRIA1 may be involved in susceptibility to DSM-IV-TR schizophrenia.
|
16526023 |
2006 |
Schizophrenia
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
To determine whether gene expression of AMPARs and/or AMPAR binding proteins, which control response/sensitivity of AMPAR-bearing neurons to glutamate, are altered in schizophrenia, mRNA expression and abundance of AMPAR subunits (GluR1-4) and several AMPAR binding proteins (SAP97, PICK1, GRIP, ABP) were measured in the dorsolateral prefrontal cortex (DLPFC) and the occipital cortex of elderly schizophrenia patients (n = 36) and matched normal controls (n = 26) by quantitative real-time PCR.
|
15696539 |
2005 |
Schizophrenia
|
0.500 |
AlteredExpression
|
disease |
BEFREE |
In conjunction with earlier findings of reduced hippocampal GluR1 and GluR2 expression and a loss of [3H]KA binding sites, these data show that schizophrenia is associated with impaired expression of both AMPA- and KA-preferring ionotropic glutamate receptors.
|
9099808 |
1997 |
Schizophrenia
|
0.500 |
Biomarker
|
disease |
BEFREE |
GluR1 and GluR2 mRNAs were less abundant per neuron in CA4 and CA3 in schizophrenia than in controls.
|
7609609 |
1995 |